< Return to Partners: List

Predictors of Severity of Alzheimer's Disease (PSAD)

Established in 1989, the Predictors of Severity of Alzheimer's Disease (PSAD) study has "followed two clinic-based cohorts of AD patients recruited from three major medical centers, and [has] made major progress in characterizing the natural history of AD and identifying predictors of disease course." Because the "ability to predict the length of time from disease onset to major disease outcomes in individual patients with Alzheimer's disease (AD) has important implications for patient care, the development of interventions and public health," the PSAD study aims to "further the understanding of disease progression in order to develop predictor algorithms to address this issue." (http://grantome.com/grant/NIH/R01-AG007370-24)

Additional Information

  • Principal Investigator(s)
  • Yaakov Stern, Columbia University
  • Partner Organization Affiliation
  • Columbia University (New York, NY)
  • Mount Sinai (New York, NY)
  • Grant No.
  • R01AG007370
  • Partnered with MedRIC In
  • 2017

Connect

  • Website
  • N/A

Cohort Size

Information icon.

~6,900

Partner Data Categories

Disclaimer

These data categories provide a MedRIC overview of the data in PSAD's data documentation, not an exhaustive catalog. As such, the partner's dataset may contain additional information not presented in this list.
  • Functional Capacities
  • Disability, Memory
  • Health Circumstances
  • Alzheimer's Disease, Medication Utilization
  • Wealth and Employment Histories
  • Economic Burden, End-of-Life Costs

CMS Files Available to Request?

Yes

Years

CMS File Type

Encryption Level (Standard, Geographic, and/or Provider)

2011-2012

Denominator (DN) Research Files

Standard

2013-2016

Master Beneficiary Summary File (MBSF) Research Files

Standard

2011-2016

Parts A & B Research Files

Standard

2006-2016

Part D Drug Event (PDE) Research Files

Standard